Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Current Assets (2019 - 2026)

Immatics (IMTX) posted Current Assets of $586.7 million for Q4 2025, up 9.57% sequentially from $535.5 million in Q3 2025, and down 12.79% YoY from $672.7 million in Q4 2024.

Analysis

Immatics (IMTX) Current Assets (2019 - 2026) Analysis & Trends

Immatics has reported Current Assets for 7 years, with the latest figure at $586.7 million in Q4 2025.

  • Quarterly Current Assets fell 12.79% year-over-year to $586.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $586.7 million (down 12.79% YoY) and the FY2025 annual result came in at $569.4 million, down 16.43% from the prior year.
  • Current Assets grew to $586.7 million in Q4 2025 per IMTX's latest filing, from $535.5 million in the prior quarter.
  • Over five years, Current Assets peaked at $672.7 million in Q4 2024 and troughed at $174.1 million in Q4 2021.
  • A 5-year average of $434.8 million and a median of $408.1 million in 2023 frame the typical range for Current Assets.
  • The widest YoY moves for Current Assets: up 135.48% in 2021, down 38.89% in 2021.
  • Over 5 years, Current Assets stood at $174.1 million in 2021, then jumped by 120.99% to $384.8 million in 2022, then advanced by 25.65% to $483.5 million in 2023, then surged by 39.14% to $672.7 million in 2024, then decreased by 12.79% to $586.7 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods registered $586.7 million, $535.5 million, and $570.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 12.54 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 18.45 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.07 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.82 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.03 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 7.22 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.62 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.76 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.63 Bn
10 Immatics 1.17 Bn 711.21 Mn - 498.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 498.88 Mn
Mar 31, 2026 567.62 Mn
Dec 31, 2025 586.69 Mn
Sep 30, 2025 535.45 Mn
Jun 30, 2025 570.44 Mn
Mar 31, 2025 603.32 Mn
Dec 31, 2024 672.74 Mn
Sep 30, 2024 563.14 Mn
Jun 30, 2024 602.11 Mn
Mar 31, 2024 639.21 Mn
Dec 31, 2023 483.50 Mn
Sep 30, 2023 419.11 Mn
Jun 30, 2023 397.05 Mn
Mar 31, 2023 370.36 Mn
Dec 31, 2022 384.79 Mn
Sep 30, 2022 324.98 Mn
Jun 30, 2022 358.56 Mn
Mar 31, 2022 291.72 Mn
Dec 31, 2021 174.12 Mn
Sep 30, 2021 212.43 Mn